Celina Cybulska, Ph.D. - Deputy Manager of the INVICTA Molecular Biology Lab

NGS technology – the best solution for preimplantation diagnosis of reciprocal translocations

PGD TRS is dedicated to all patients diagnosed with reciprocal translocations i.e., exchanges of genetic material between different chromosomes. Such mutations are detected by karyotype testing. […]

INVICTA PGS-NGS 360°™ chromosome screening clearly improves IVF outcomes.

A healthy 30-year-old woman has only about a 20% chance each month to get pregnant naturally. Worldwide 1 in 6 couples experience infertility problems at least […]

Quality management system for INVICTA PGS-NGS 360°™

INVICTA Medical Diagnostic Laboratory is accredited according to ISO 9001:2008 and ISO 14001:2004. Invicta Laboratory operates based on the principles of best laboratory practice. Protocols and […]

Test Fragment Accuracy – simple way to measure Your PGS/PGD procedure quality

Next generation sequencing (NGS) technologies produce millions of sequences in a single sequencing run. Prior to analyzing this huge amount of data, it is crucial to […]

How massive parallel sequencing will help You to increase Your success rate?

Development of high-throughput DNA sequencing technologies that omit time consuming and labour intensive steps have opened new possibilities in life sciences. The beginning of the 21st […]